نتایج جستجو برای: mcf7 cancer cell

تعداد نتایج: 2332613  

Journal: :Anticancer research 2005
Yan Ansquer Agnès Legrand Annie-France Bringuier Nathalie Vadrot Bernard Lardeux Laurent Mandelbrot Gérard Feldmann

BACKGROUND Inherited mutations of the BRCA1 gene are responsible for hereditary breast and ovarian cancer syndrome. However, little is known of how disruption of BRCA1 functions preferentially increases cancer risk in hormone-dependent organs. We aimed to study whether BRCA1 was regulated by progesterone in the MCF7 breast cancer cell line. MATERIALS AND METHODS MCF7 breast cancer cells were ...

2015
Tahereh Komeili-Movahhed Shamileh Fouladdel Elmira Barzegar Shekoufeh Atashpour Mohammad Hossein Ghahremani Seyed Nasser Ostad Zahra Madjd Ebrahim Azizi

OBJECTIVES Multidrug resistance (MDR) of cancer cells is a major obstacle to successful chemotherapy. Overexpression of breast cancer resistance protein (BCRP) is one of the major causes of MDR. In addition, it has been shown that PI3K/Akt signaling pathway involves in drug resistance. Therefore, we evaluated the effects of novel approaches including siRNA directed against BCRP and targeted the...

2015
Rebecca Lamb Bela Ozsvari Gloria Bonuccelli Duncan L. Smith Richard G. Pestell Ubaldo E. Martinez-Outschoorn Robert B. Clarke Federica Sotgia Michael P. Lisanti

Tumor cell metabolic heterogeneity is thought to contribute to tumor recurrence, distant metastasis and chemo-resistance in cancer patients, driving poor clinical outcome. To better understand tumor metabolic heterogeneity, here we used the MCF7 breast cancer line as a model system to metabolically fractionate a cancer cell population. First, MCF7 cells were stably transfected with an hTERT-pro...

Journal: :iranian journal of pharmaceutical research 0
fatemeh kalalinia biotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran fatemeh elahian department of pharmaceutical biotechnology, school of pharmacy, zanjan university of medical sciences, zanjan, iran fatemeh mosaffa department of pharmaceutical biotechnology, school of pharmacy, mashhad university of medical sciences, mashhad, iran javad behravan department of pharmaceutical biotechnology, school of pharmacy, mashhad university of medical sciences, mashhad, iran

elevated expression of the drug efflux transporter abcg2 seems to correlate with multidrug resistance of cancer cells. specific cox-2 inhibitor celecoxib has been shown to enhance the sensitivity of cancer cells to anticancer drugs. to clarify whether abcg2 inhibition is involved in the sensitizing effect of celecoxib, we investigated whether the expression of abcg2 in breast cancer cell lines ...

Elevated expression of the drug efflux transporter ABCG2 seems to correlate with multidrug resistance of cancer cells. Specific COX-2 inhibitor celecoxib has been shown to enhance the sensitivity of cancer cells to anticancer drugs. To clarify whether ABCG2 inhibition is involved in the sensitizing effect of celecoxib, we investigated whether the expression of ABCG2 in breast cancer cell lines ...

2012
Juliette Adjo Aka Sheng-Xiang Lin

T47D and MCF7 are two human hormone-dependent breast cancer cell lines which are widely used as experimental models for in vitro and in vivo (tumor xenografts) breast cancer studies. Several proteins involved in cancer development were identified in these cell lines by proteomic analyses. Although these studies reported the proteomic profiles of each cell line, until now, their differential pro...

2017
YanYang Wang AiBin Guo XiuBin Liang Min Li Ming Shi Yan Li Gareth Jenkins XiaWen Lin XueFei Wei ZhiJun Jia XueFeng Feng DongMing Su WanHua Guo

Estrogen receptor alpha positive (ER+) of breast cancer could develop resistance to antiestrogens including Tamoxifen. Our previous study showed that the E3 ubiquitin ligase HRD1 played an important role in anti-breast cancer. However, its role in chemotherapy resistance hasn't been reported. In this study, we found that HRD1 expression was downregulated in Tamoxifen-resistant breast cancer cel...

Elevated expression of the drug efflux transporter ABCG2 seems to correlate with multidrug resistance of cancer cells. Specific COX-2 inhibitor celecoxib has been shown to enhance the sensitivity of cancer cells to anticancer drugs. To clarify whether ABCG2 inhibition is involved in the sensitizing effect of celecoxib, we investigated whether the expression of ABCG2 in breast cancer cell lines ...

Background and Objectives: Cancer is one of the most deadly diseases in the present age and its conventional therapies have had low success. Toxin therapy of cancer is a new therapeutic approach, which has attracted the attention of pharmaceutical specialists. Diphtheria toxin consists of three functional, transducing, and binding domains, that the functional part inhibits protein synthesis and...

2012
Hélène Valque Valérie Gouyer Frédéric Gottrand Jean-Luc Desseyn

The mucin MUC5B has a critical protective function in the normal lung, salivary glands, esophagus, and gallbladder, and has been reported to be aberrantly expressed in breast cancer, the second leading cause of cancer-related deaths among women worldwide. To understand better the implication of MUC5B in cancer pathogenesis, the luminal human breast cancer cell line MCF7 was transfected with a v...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید